8-K: Vireo Growth Wins Schwazze Asset Bid for $111M

Vireo Growth Inc. secured a majority of Schwazze's assets through a $111 million credit bid, initiating a restructuring plan.

Summary

• Vireo Growth Inc., through its wholly-owned subsidiary Vireo Health of Colorado, LLC, entered into a restructuring support agreement (RSA) with Schwazze and related entities on October 10, 2025.
• The RSA outlines a plan to restructure Schwazze's operations and capital structure, including the purchase of a majority of Schwazze's total assets (the Asset Sale) by a newly-formed entity (NewCo) to be majority-owned by Vireo Growth Inc., and the liquidation of Schwazze's remaining assets.
• Vireo Growth Inc. had previously acquired a majority of Schwazze's outstanding principal amount of 13% Senior Secured Convertible Notes due December 7, 2026.
• On November 13, 2025, the Asset Sale took place, and the collateral agent, acting at the direction of Vireo Growth Inc., credit bid approximately $111 million principal amount of Senior Secured Notes.
• Vireo Growth Inc.'s credit bid was the winning bid at the Asset Sale.
• Following the winning bid, Schwazze entered into an asset purchase agreement with NewCo on November 13, 2025.
• The asset transfer to NewCo is subject to regulatory approvals and other closing conditions.
• NewCo will assume certain specified liabilities of Schwazze and discharge the Senior Secured Notes included in the Credit Bid.
• At the closing of the Asset Sale, equity interests in NewCo will be distributed by the collateral agent to the holders of the Senior Secured Notes and certain other parties.

Sentiment

Score: 7

Explanation: The filing reports the successful execution of a strategic asset acquisition through a credit bid, which is a positive development for Vireo Growth Inc. However, the transaction is still subject to regulatory approvals and other closing conditions, introducing some residual uncertainty.

Positives

• Vireo Growth Inc. successfully acquired a majority of Schwazze's assets, potentially expanding its market presence and operational footprint.
• The acquisition was achieved through a credit bid of existing Senior Secured Notes, which can be a cost-effective method of acquiring assets by converting debt into equity or assets.
• The restructuring plan aims to streamline operations and capital structure of Schwazze's acquired assets under NewCo, potentially leading to improved efficiency and profitability.

Negatives

• The transaction is subject to regulatory approvals and other closing conditions, which introduces a degree of uncertainty and potential for delays.
• NewCo will assume certain specified liabilities of Schwazze, which could impact its financial health depending on the nature and extent of these liabilities.
• The liquidation of Schwazze's remaining assets and winding down of its remaining operations could be complex and may involve unforeseen costs or challenges.

Risks

• The asset transfer to NewCo is subject to receipt of regulatory approvals, which could delay or prevent the closing of the transaction.
• Other unspecified closing conditions must be met for the asset purchase agreement to finalize.
• The liquidation of Schwazze's remaining assets and winding down of its remaining operations could present unforeseen challenges or liabilities.

Future Outlook

The plan involves restructuring Schwazze's operations and capital structure, with a newly-formed entity (NewCo) ultimately majority-owned by Vireo Growth Inc. taking over a majority of Schwazze's assets. The remaining Schwazze assets will be liquidated, and operations wound down, subject to regulatory approvals and other closing conditions.

Management Comments

• "The registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized." (Signed by Tyson Macdonald, Chief Financial Officer)

Industry Context

This transaction likely reflects ongoing consolidation and strategic asset acquisition within the cannabis industry. Companies like Vireo Growth Inc. may seek to expand market share, acquire distressed assets, or optimize their operational footprint through such restructuring and M&A activities. Schwazze, operating as Medicine Man Technologies, Inc., is a known entity in the cannabis space, and this event signifies a significant shift in its operational structure.

Stakeholder Impact

• **Shareholders (Vireo Growth Inc.):** Potential for increased asset base, market share, and operational synergies, subject to successful integration and regulatory approval. This could lead to long-term value creation.
• **Holders of Senior Secured Notes (Schwazze):** Will receive equity interests in NewCo at closing, indicating a conversion of their debt into equity in the restructured entity, which may offer a path to recovery.
• **Employees (Schwazze):** The restructuring and winding down of Schwazze's remaining operations imply potential job impacts for employees of the original entity, while NewCo will likely establish its own workforce.
• **Creditors (Schwazze):** Senior Secured Notes are being discharged as part of the transaction; other specified liabilities are being assumed by NewCo, while remaining liabilities will be addressed in the liquidation process.

Next Steps

• Receive regulatory approvals for the asset transfer to NewCo.
• Fulfill other closing conditions for the asset purchase agreement.
• Transfer assets from Schwazze to NewCo.
• Distribute equity interests in NewCo to holders of Senior Secured Notes and other parties.
• Liquidate Schwazze's remaining assets and wind down its remaining operations.

Key Dates

Recommendation

Vireo Growth Inc. has successfully executed a strategic acquisition of a majority of Schwazze's assets via a credit bid, which could be a positive long-term development for the company's growth and market position. This move allows Vireo to expand its operational footprint and potentially consolidate its position in the industry. However, the transaction is still contingent on regulatory approvals and other closing conditions, which introduces a degree of uncertainty. Furthermore, the assumption of certain liabilities by NewCo and the complexities of integrating the acquired assets and winding down Schwazze's remaining operations warrant a cautious approach. Investors should hold to observe the successful completion of the transaction, the integration process, and the subsequent financial performance of the combined entities before making a more definitive investment decision.

Keywords

Vireo Growth Inc., Schwazze, Medicine Man Technologies, Asset Acquisition, Restructuring, Credit Bid, Senior Secured Notes, Cannabis Industry, Corporate Governance, M&A, Distressed Assets